Introduction
The induction of a cellular response similar to DNAdamage-sensing signals has been shown during human immunodeficiency virus type-1 (HIV-1) infection (Daniel et al., 1999 (Daniel et al., , 2003 (Daniel et al., , 2004 Lau et al., 2004) . The synthesis of linear HIV-1 DNA in the cytoplasm by reverse transcription and the integration process of HIV-1 DNA into the host genome are thought to be possible triggers for the DNA-damage signals (Lau et al., 2004 (Lau et al., , 2005 . When chromosomal DNA is damaged (DSB; DNA double-strand break), two kinds of kinases (ATM and ATR) are initially activated to exert checkpoint control on cell cycle (Abraham, 2001) . When caffeine, which is known to inhibit both ATR and ATM, is administered in conjugation with the viral infection, the integration of viral DNA into the host genome is impaired . Additionally, data showing that the recently developed ATM inhibitor KU55933 decreased the copy number of the integrated HIV-1 DNAs strongly suggest that an ATM-dependent signal has a key role in viral transduction (Lau et al., 2005) . In addition to the mechanism of viral infection, HIV-1-induced DSBs or their signals have an impact on the approaching AIDS pathogenesis, especially for cancer development. A high incidence of malignant tumors has been reported in AIDS patients (Mayer et al., 1995; Biggar et al., 1996; Straus, 2001) , and recent observations have indicated that tumor development is observed even in HIV-1-positive patients who do not show any immunocompromised manifestations (Knowles, 2003) . These data suggest that HIV-1 infection is by itself oncogenic (Laurence and Astrin, 1991) , but the viral protein responsible for ATM activation during HIV-1 infection has not been well characterized.
Vpr, an accessory gene product of HIV-1, impairs the progression of the cell cycle at G2/M phase (He et al., 1995; Goh et al., 1998) . Vpr is thought to inactivate Cdc2, which is a component of maturation-promoting factor, by phosphorylating tyrosine 15 (Bukrinsky and Adzhubei, 1999; Elder et al., 2002) . Recent studies have shown that Vpr-induced G2 arrest is attenuated by the introduction of wee-1 siRNA or deletion of the wee-1 gene (Yuan et al., 2004) . Together with data on a dominant-negative mutant of ATR and its siRNA, ATR-Chk2-Wee-1 as a summarized signal pathway was postulated to be responsible for the Vpr-induced G2 arrest (Roshal et al., 2003; Yuan et al., 2004; Zimmerman et al., 2004) . As an earlier study demonstrated that ATM was not important for Vpr-induced G2 arrest (Bartz et al., 1996) , there have been no reports that describe the activation of ATM under Vpr expression. To investigate the Vpr-induced cell cycle abnormalities, we established a MIT-23 cell line, in which Vpr expression is tightly regulated by a tetracycline promoter (Shimura et al., 1999b) . We found that the continuous expression of Vpr induced the formation of TUNELpositive micronuclei and increased the rate of gene amplification (Shimura et al., 1999a) , implying that Vpr induces DSBs. Through an analysis with a pulse-field gel electrophoresis on HIV-1 infected cells, we recently detected an altered migration pattern of high-molecularweight genomic DNA (Tachiwana et al., 2006) , also implying that Vpr induces DSBs. Thus, it is now important to clarify whether a cellular response dependent on ATM, a kinase activated selectively by DSBs (O'Connell et al., 2000; Shiloh, 2001) , is really induced by Vpr, and if so, we need to determine whether Vpr is the major viral protein responsible for ATM activation.
DNA damage is induced by reactive oxygen species, ionizing radiation, and chemicals (Abraham, 2001) , and are repaired by homologous recombination (HR) or nonhomologous DNA end-joining (NHEJ) pathways van Gent et al., 2001) . Once a DSB is generated, a 3 0 single-stranded DNA tail is processed, where replication protein A (RPA) and Rad51, an eukaryotic homologue of the bacterial DNA strand exchange protein RecA (Cromie et al., 2001; West, 2003) , accumulate. It was shown that p53 and BRCA2 phosphorylated at serine 3291 bind Rad51 and suppress its HR activity (Dong et al., 2003; Linke et al., 2003; Yoon et al., 2004) . Functional BRCA1 and 2 are required when DSBs occur; otherwise, genomic instability is induced, as observed in cancer-prone individuals with mutations of these genes (van Gent et al., 2001; Dong et al., 2003) .
In this report, we first show that Vpr induced an ATM-dependent cellular signal. The cellular response under Vpr expression was similar to that caused by X-ray irradiation involving BRCA1, RPA and Rad51. We next demonstrate that Vpr increased the frequency of HR in an ATM-dependent manner. Data support the idea that Vpr induces DSBs. The possible role of Vpr in viral infection and in HIV-1-associated malignant tumor development is discussed.
Results

DSB-induced cellular signals by Vpr
Initially, we examined whether DSB-dependent cellular signals were induced by HIV-1 infection. HT1080 cells were infected with viruses without (R À ) or with wildtype vpr (R þ ), and an immunohistochemical analysis was performed. As shown in Figure 1a , g-H2AX accumulated after infection with the R þ virus (right panels) but not with the R À virus (Figure 1a , middle panels). Western blot analysis demonstrated a high-level expression of g-H2AX with the phosphorylation of p53 in cells infected with the R þ virus (Figure 1b , lanes 4 and 5). Viral concentrations of 50 and 100 ng/ml of p24 were sufficient for the induction of g-H2AX. In contrast, the R À virus did not induce p53 phosphorylation, although it slightly increased p53 expression ( Figure 1b, lanes 2 and 3) .
To characterize the intracellular signals specifically induced by Vpr, we used MIT-23 cells, in which vpr mRNA expression was tightly regulated by the tetracycline promoter (Shimura et al., 1999b) . In MIT-23 cells, Vpr expression was observed in 48 h after treatment of 3 mg/ml of doxycycline (DOX) (Figure 2a ). Under such conditions, we observed focus formation of ATM phosphorylated at serine 1981 (ATM-p) ( Figure 2b , upper panels) and g-H2AX (lower panels). In contrast, focus formation of these molecules was not observed in MIT-23 cells without DOX treatment (left panels). Additionally, we did not detect focus formation of To compare the Vpr-induced DSB-dependent signals with those by X-ray irradiation, HT1080 cells were irradiated with 7.5 Gy of X-rays, and the evoked signals were analysed. As shown in Figure 2b (right panels), X-ray-induced DSBs generated focus formation of ATM-p (Figure 2b , upper panel) and g-H2AX (lower panel). Additionally, Western blot analysis clearly demonstrated the phosphorylation of both Chk2 and p53 (lane 3 and 4). Data suggest that Vpr-induced DNA-damage signals are quite similar to those triggered by a well-characterized DSB inducer.
Mobilization of cellular factors that are involved in repair of DSBs
To further characterize the molecules activated as a cellular response to Vpr-induced DSBs, we investigated BRCA1, RPA and Rad51 mobilized for repair of DSBs (West, 2003) . As shown in Figure 3 , the immunohistochemical analysis carried out under Vpr expression clearly detected focus formation of these molecules (Figure 3 ). In contrast, control cells did not show remarkable modification of these molecules. Again, X-ray irradiation also induced the same modification of the molecules (Figure 3 , right panels).
It has been proposed that during the DSB repair process, Rad51 is released from a complex of p53 and becomes competent for HR Bertrand et al., 2004) . To address this possibility, we compared the physical association of Rad51 and p53 in the insoluble chromatin fraction before and after the induction of Vpr expression. The interaction of these molecules was eliminated following Vpr expression ( Figure 4a , lanes 3 and 4; arrow). The level of the complex formation of p53 and Rad51 decreased by 35% compared to the control. This finding is reproducibly observed, implying the possibility that Vpr binds either Rad51 or p53 and ceases their interaction. We examined the direct interaction of Vpr and Rad51 by using recombinant proteins, but did not obtain positive results (data not shown). As it has been shown that Vpr does not interact with p53 (Sawaya et al., 1998) , the mechanism of dissociation of p53 and Rad51 in Vpr-expressing cells remains to be clarified.
We also compared this molecular change with that induced by X-ray irradiation. HT1080 cells were irradiated, and the subsequent change of the interaction of Rad51 and p53 was examined. As observed in Figure 4a , the interaction between Rad51 and p53 in the insoluble chromatin fraction was also abolished (Figure 4b, compare lanes 3 and 4, arrow) . Data suggest that Vpr modifies Rad51 in the same way as X-ray irradiation. The signals for ATM-p and g-H2AX are depicted as red spots in the nucleus (blue). (c) Western blot analysis of proteins involved in the DSB-induced signal pathway. Cell lysates of MIT-23 cells (lanes 1 and 2) were subjected to analysis. As a positive control, HT1080 cells were irradiated at 7.5 Gy, collected after 30 min, and subjected to analysis.
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Increased rate of HR by Vpr
DSBs must be correctly repaired, or genome integrity cannot be maintained (West, 2003) . As Vpr induces DSBs and cellular factors such as Rad51 and BRAC1 are mobilized under Vpr expression, we hypothesized that the rate of HR increased in Vpr-expressing cells. To measure the rate of HR, we first utilized a system invented by Slebos and Taylor (2001) that could monitor extrachromosomal recombination within a plasmid DNA (pBHRF). pBHRF contains a truncated EBFP cassette, which forms a functional EGFP following intramolecular HR (Slebos and Taylor, 2001 ). We cotransfected HT1080 with pBHRF and a plasmid DNA encoding Vpr and examined the effects of Vpr on HR.
After 72 h of transfection, the EGFP-and EBFPpositive cells were counted by flow cytometry (Figure 5a , regions a and b, respectively). Then, the frequency of HR was calculated as a ratio of number of cells positive for EGFP and EBFP. It increased about 2.5-fold by co-transfection of a plasmid encoding Vpr. Vpr-induced enhancement of HR was reproducibly observed (Po0.05), and the representative results are shown in Figure 5b .
Although the experiments with pBHRF strongly suggested that Vpr increases HR, it has been demonstrated that an extrachromosomal HR does not correlate with intrachromosomal HR. Waldman and Liskay (1987) clearly demonstrated that the frequency of and 2) and insoluble chromatin fractions (lanes 3 and 4) subjected to analysis. Proteins that were immunoprecipitated (IP) with the anti-p53 antibody (ap53) were analysed by Western blot analysis (WB) with the ap53 and aRad51 antibodies, respectively. Input lysates were also analysed by the same antibodies and ahistone H3 (HH3). The cell lysate with (lanes 2 and 4) or without (lanes 1 and 3) Vpr expression are shown (a). The same analysis was performed on X-ray irradiated cells (b). Arrowheads indicate Rad51 recovered by ap53 antibody.
Double-strand DNA breaks and homologous recombination by Vpr C Nakai-Murakami et al extrachromosomal and intrachromosomal recombination rates are differentially influenced by the mismatch of the nucleotides. To measure the rate of intrachromosoml HR under Vpr expression correctly, we prepared stable transfectants derived from HT1080 cells that had been introduced with pDR-GFP. pDR-GFP is a reporter construct that will generate an intact EGFP gene by gene conversion after digestion with a rare cutting enzyme, I-SceI (Pierce et al., 1999) . We obtained two independent transfectants, HT/DR-GFP-1 and -2, that possessed an integrated exogenous plasmid DNA competent for a short tract gene conversion (Supplementary information 1a) (Pierce et al., 1999) . Then, HT/ DR-GFP cells were infected with adenoviruses of either Adbgal or Ad-SceI-NG and subjected to analysis of GFP-positive cells after 72 h. After infection with AdSceI-NG, both clones gave increased numbers of GFPpositive cells (about 0.5%) (Supplementary information 1b and c). In contrast, Adbgal, control adenovirus, induced very few cells positive for GFP (o0.1%) (Supplementary information 1b and c) .
We then examined the influence of Vpr on the rate of HR. First, we introduced a plasmid DNA encoding Vpr or its control plasmid DNA, but it was not possible to assess the effects of Vpr correctly because transfection of plasmid DNA by itself influenced the rate of HR (data not shown). It has been well reported that Vpr enters cells and expresses its biological activity when added to the cell culture (Jenkins et al., 1998; Henklein et al., 2000; Huang et al., 2000; Taguchi et al., 2004) . These observations encouraged us to perform the experiments by adding Vpr to cells exogenously with subsequent measurement of GFP-positive cells. We prepared a recombinant Vpr (rVpr) (Hoshino et al., submitted) , and we first checked whether exogenously added rVpr induces DSB-triggered cellular response. rVpr (50 ng/ ml; 3.7 nM) added to the medium induced DSBdependent signals (Figure 6a ), whereas glutathione S transferase (GST), an irrelevant recombinant protein that was expressed in bacteria and purified, did not (right panels). Interestingly, the addition of the ATM inhibitor KU55937 abolished rVpr-induced focus formation of ATM-p and g-H2AX (Figure 6a ).
When rVpr was added to HT/DR-GFP-1 (clone-1), HR especially after infection with Ad-SceI-NG-infected was definitely enhanced (about 1.5%), whereas it was not remarkably changed by the addition of GST ( Figure  6b and c, left panel) . The difference in GFP-positive numbers after treatment with rVpr and GST was statistically significant (Po0.01). As more striking evidence, the addition of KU55933 significantly attenuated the increased number of GFP-positive cells caused by rVpr (Figure 6c , right panel) (Po0.01). Data indicate that ATM is a critical molecule for the Vpr-induced enhancement of HR.
Discussion
Vpr induces DSBs and enhances HR
In this study, we showed that Vpr activates the ATMdependent signal pathway involving Chk2 phosphorylation with focus formation of Rad51, BRCA1 and g-H2AX. We previously reported that Vpr increases the rate of gene amplification (Shimura et al., 1999a) , and a subsequent analysis by fluorescence in situ hybridization of amplified DNA suggested that a bridge-breakage fusion cycle, possibly triggered by DSBs (Ishizaka et al., 1995) , was a relevant mode of Vpr-induced gene amplification. Data shown in the present study well supports our expectation that Vpr enhances gene amplification by causing DSBs (Shimura et al., 1999a) .
We observed that the frequency of HR increased in response to Vpr. We examined the rate of HR by two systems measuring extrachromosomal recombination (Slebos and Taylor, 2001 ) and intrachromosomal recombination (Pierce et al., 1999) . Both systems detect cells that are positive for GFP generated by gene conversion. Although it has been claimed that these two modes of HR do not always equally detect cellular recombinogenic conditions, our present data revealed that both systems detected the effects of Vpr on HR. It is interesting to note that the intrachromosomal recombination system used in the current study detects HR at Double-strand DNA breaks and homologous recombination by Vpr C Nakai-Murakami et al the specific site in the genome, where DSB is induced by expressing I-SceI, a rare-cutting enzyme (Anglana and Bacchetti, 1999) . We used two cell lines, both of which contained reporter constructs that were competent for a short tract gene conversion (Pierce et al., 1999;  Supplementary information 1), and we reproducibly detected enhancement of HR after treatment with Vpr. Data suggest that Vpr has an indirect effect on HR, indicating that DBSs at one locus contribute to transactivation of HR at a different site.
In response to Vpr-induced DSBs, BRCA1 and RPA accumulated as foci (Figure 2b) , and the association of Rad51 and p53 in the chromatin fraction was eliminated (Figure 3a and b) . It has been reported that p53 associates with several proteins including BLM, BRCA1, BRCA2, Rad52 and RPA (Yamaguchi-Iwai Marmorstein et al., 1998; Zhang et al., 1998; Linke et al., 2003; Sengupta et al., 2003) and inhibits the Rad51-dependent HR (Cromie et al., 2001; Linke et al., 2003) . When DSBs were induced, the association of p53 and Rad51 was prevented by an unknown mechanism. As the reduction of Rad51 and p53 interaction was also observed after irradiation (Figure 3c) , it is likely that the Vpr-activated DNA-damage signaling overlaps with the cellular signals evoked by irradiation.
Biological relevance of Vpr-induced DSBs and HR for HIV-1 infection
Vpr expression enhances the rate of HR, but several reports suggest that NHEJ rather than HR contributes to viral infection (Daniel et al., 1999; Li et al., 2001; Jeanson et al., 2002; Lau et al., 2005) . Additionally, Rad52, a cellular component of HR, was shown to work as a suppressive factor for HIV-1 transduction (Lau et al., 2004) . Together with data that the deletion of genes involved in HR, such as XRCC2 or XRCC3, did not alter the rate of viral integration (Chan et al., 2004) , it seems that upregulation of HR by Vpr does not by itself contribute to viral transduction. In contrast, chemical compounds that generate DSBs increase the rate of integration of viral DNA into the host genome (Groschel and Bushman, 2005) . This phenomenon has been explained by delayed progression at the G2/M phase due to DSBs. Additionally, caffeine and caffeine-related methylxanthines are known to impair HIV-1 infection (Nunnari et al., 2005) , and an ATM inhibitor, KU55933, is known to decrease the integration of viral DNA into host genome (Lau et al., 2005) . These observations suggest that a DSB-induced cellular signal, not HR, is important for viral integration, and that Vpr-induced DSB contributes to efficient viral integration in an ATM-dependent manner. An important issue to clarify is how cellular signals activated by ATM contribute to increased viral integration.
Possible mechanism of Vpr-induced DSBs and cell cycle abnormality The mechanism of Vpr-induced DSBs is presently obscure. In the previous work, we showed that DSBs are induced by incubating isolated nuclei with purified recombinant Vpr protein (Tachiwana et al., 2006) . A purified Vpr possessed DNA binding activity, but it did not show any nuclease activity or activity of nicking DNAs. Additionally, Vpr is present in the chromatin fraction (Ishizaka, unpublished results, Lai et al., 2005) , implying the possibility that Vpr induces DSBs by modifying a chromatin structure to allow nucleases easy access. Another possibility is that Vpr associates with uncharacterized nuclease and recruits its activity to the vicinity of chromosomes. Studies are ongoing to identify cellular factor(s) that facilitate recruitment of Vpr to chromatin and induction of DSBs.
It is commonly accepted that Vpr-induced cell cycle abnormality is observed at the G2/M phase but not at the G1/S phase (Mahalingam et al., 1998) . Actually, we observed cellular accumulation at the G2/M phase in MIT-23 cells when Vpr expression was initiated (Shimura et al., 1999b) . Our present observation on the activation of ATM-dependent signal pathway by Vpr envisages that Vpr-induced cell cycle abnormality depends on ATM activation. A recent study, however, has shown that the ATR-Chk1 pathway, but not ATMChk2, is necessary for Vpr-induced G2 arrest (Roshal et al., 2003; Zimmerman et al., 2004) . One possible explanation is that DSB-induced G2 arrest, for example, by X-ray irradiation largely depends on ATR-dependent signaling (Brown and Baltimore, 2003) . The molecular linkage between ATM activation by Vpr and Vprinduced cell cycle abnormality, however, needs to be carefully investigated.
Impact of Vpr-induced DSBs on the mechanism of tumor development in HIV-1-positive patients We showed that DSBs and an increased rate of HR were induced when rVpr was added to the culture medium exogenously (Figure 6 ). Recently, we also found that Vpr is present in serum of HIV-1-positive patients (Levy et al., 1994) at the concentration of about 0.7 nM (Hoshino et al., submitted) . In the current study, we used 3.7 nM of rVpr to obtain the definite activity inducing DSBs, but it would be possible that the high concentration of Vpr is present in the foci of HIV-1 infection, suggesting that DSBs can be generated in the cells within HIV-1-positive patients. The finding that Vpr is present in serum impacts the understanding of the mechanism of tumor development in HIV-1 positive patients. As reported by Biggar et al., the relative risk of Figure 6b (right panel). KU55933 (ATMi) was added at a concentration of 1 mM at the same time that rVpr was added. As a control, the corresponding amount of dimethylsulfoxide (final concentration: 0.1% volume), which was used as a solvent for the compound, was included. ATMi significantly inhibited the rate of HR (Po0.01).
Double-strand DNA breaks and homologous recombination by Vpr C Nakai-Murakami et al malignancy in AIDS patients was estimated to be 60-to1000-fold higher than healthy controls (Mayer et al., 1995; Biggar et al., 1996; Straus, 2001) . Although it has been thought that an impaired cellular immunity under AIDS conditions permits the development of tumorigenesis (Knowles, 2003) , recent observations indicate that non-AIDS-defining malignancies, tumors found in HIV-1-positive patients who have no deteriorated cellular immunity, are frequently observed in HIV-1-positive patients (Herida et al., 2003; Burgi et al., 2005; Lim and Levine, 2005) . As antiretroviral therapy can effectively protect patients from severe infectious diseases (Chadburn and Cesarman, 1997; ElenitobaJohnson and Jaffe, 1997) , development of malignant tumors will be a critical prognostic factor of HIV-1 positive patients in the future. More precise study is required to clarify the molecular linkage of Vpr and malignant transformation.
Materials and methods
Cell culture and establishment of HT/DR-GFP HT1080, a human fibrosarcoma cell line (JCRB9113; the Healthy Science Research Resources Bank), and its sublines were maintained at 371C and 5% CO 2 in Dulbecco's modified Eagles medium (D-MEM) that was supplemented with 10% fetal bovine serum (FBS). The MIT-23 cell line was derived from HT1080 cells, in which Vpr expression is controlled by a tetracycline promoter, as described by Shimura et al. (1999b) . For Vpr induction, 3 mg/ml DOX (Sigma, St Louis, MO, USA) was used. To obtain HT/DR-GFP, HT1080 cells were transfected with an inactive GFP expression cassette plasmid (pDR-GFP) and selected by puromycin (1 mg/ml), and clonal cell lines were established.
HIV infection
We used pseudotyped viruses that were defective for an envelope protein with vpr (R þ ) or without vpr (R À ). HIV vectors were produced by transient transfection of 293T cells (Tokunaga et al., 2001; Shimura et al., 2005) . The pNL-Luc-E À R þ or pNL-Luc-E À R À plasmid was co-transfected with pHIT/G using the transfection reagent Fugene-6 (Roche, Tokyo, Japan). Virus supernatants were collected at 48 h posttransfection. The harvested supernatants were centrifuged at 120 g for 5 min and stored at À801C. Viral titers were measured by p24 ELISA (ZeptoMetrix). The virus was diluted in D-MEM supplemented with 10% FBS and used to infect HT1080 cells at a multiplicity of infection (MOI) of 0.8, which yielded about 80% of cells that were positive for luciferase expression (data not shown).
Protein analyses
The cells were washed with phosphate-buffered saline (PBS) and resuspended in radio-immunoprecipitation assay buffer composed of 50 mM Tris-HCl, 1% NP-40, 0.25%. sodium deoxycholate, 150 mM NaCl, 1 mM EGTA, 1 mM phenylmethysulfonyl fluoride, 1 mg/ml protease inhibitor mix, 1 mM Na 2 VO 3 and 1 mM NaF. The cell suspension was sonicated. To fractionate chromatin fractions, cells were suspended in Buffer N (15 mM Tris-HCl (pH 7.5), 60 mM KCl, 15 mM NaCl, 5 mM MgCl 2 , 1mM CaCl 2 , 1 mM DTT, 2 mM Na 2 VO 3 , 250 mM sucrose, protease inhibitors) with 0.6% NP-40. Cells were incubated on ice for 5 min followed by centrifugation (2000 g) to separate cytoplasmic proteins from nuclei. Isolated nuclei were then washed twice with Buffer N followed by resuspension in Lysis buffer (10 mM PIPES (pH 6.5), 10 mM EDTA, protease inhibitors) and centrifugation (6000 g) to extract soluble nuclear proteins. Finally, chromatin was resuspended in Lysis buffer and shared by sonication on ice to extract chromatin-bound proteins. The protein concentration was determined using the BCA protein assay reagent kit (Pierce) . A 100-mg aliquot of protein from each cell extract was separated on 10% SDS-PAGE. Specific primary antibodies of p53 (Calbiochem), Chk2, ATM-S1981 (ATM-p), H2AX-S139 (g-H2AX) and histone H3 (Upstate), Chk2-T68 (Chk2-p) and p53-S15 (p53-p) (Cell Signaling) were used for analysis. A monoclonal antibody to Vpr, 8D1 (IgG2a) was raised by immunization of a full-length Vpr peptide (Peptide Institute).
Immunoprecipitation was performed using 500 mg of protein mixed with 2 mg of anti-p53 protein-specific IgG-beads. Ternary complexes of protein A-antibody-antigen were collected by centrifugation and washed three times. The immunoprecipitates were subjected to SDS-PAGE followed by Western blot analysis. To obtain a rabbit antibody to RAD51, the human Rad51 protein was expressed as a recombinant protein in the Escherichia coli strain JM109 (DE3) (Kagawa et al., 2001) , and was purified as described previously (Kurumizaka et al., 1999) . Detection of target proteins was with an enhanced chemiluminescence detection system (Amersham Biosciences).
Immunostaining
The cells were washed with PBS and fixed with 2% paraformaldehyde in PBS and ice-cold methanol. The fixed cells were permeabilized with 0.2% Triton X-100 in PBS for 5 min. After treatment with PBS containing 10% goat serum for 30 min, the cells were incubated with primary antibodies that included rabbit polyclonal antibodies against Rad51 (1:400), mouse monoclonal antibodies against ATM-p (1:100) and g-H2AX (1:100) (Upstate) and mouse monoclonal antibodies against BRCA1 (1:300) and RPA (1:1000) (Lab Vision). After 1 h of incubation at 371C, secondary antibodies conjugated with Alexa 546 (1:1000; Molecular Probes, Eugene, OR, USA) were added for 1 h at 371C. The slides were mounted in an anti-fade solution (KPL) and analysed by fluorescence microscopy.
Homologous recombination assay
The rate of extrachromosomal HR was assessed as previously described (Slebos and Taylor, 2001 ). HT1080 cells were cotransfected with pBHRF and pcDNA3.1/Vpr or pcDNA3.1 (Invitrogen). pBHRF encodes both a truncated GFP and fulllength BFP. In the absence of HR, only BFP is expressed. However, HR between the BFP and truncated GFP results in the creation of a functional GFP. The green and blue fluorescence levels were examined simultaneously using a Vantage flow cytometer (Becton-Dickinson) equipped with a 488-argon laser (GFP) and a UV (350-360 nm) laser (BFP). vpr was derived from a NL4-3 clone (Adachi et al., 1986) . Each experiment was performed at least three times, and statistical analysis was carried out by Student's t-test.
The rate of intrachromosomal HR was assessed as reported in human glioma cells (Pierce et al., 1999) . Upon infection with Ad-I-Sce-I, a kind gift from Dr F Graham (McMaster University, Canada) or Ad-Lac8 (a gift from Dr I Saito, Tokyo University) as a control, GFP-positive cells as a result of HR were analysed. KU55933, a gift from Dr M O'Connor (KuDOS Pharmaceuticals, England), was dissolved in dimethylsulfoxide (DMSO). GFP was analysed with laser scanning cytometer (LSC; Olympus, Tokyo, Japan) (Huang et al., 2006) . Cells cultured in cover slide were immersed in 0.2% Triton X-100 in PBS for 10 min. The slides were then incubated with anti-GFP antibody (1:100; Molecular Probes) before adding Alexa Fuor 488 conjugated secondary antibody (1:400; Molecular Probes). Green fluorescence emission was measured with LSC. The integrated fluorescence was measured in 10 000 cells for each sample. Each experiment was repeated three times, and statistical significance was examined.
Expression and purification of rVpr rVpr was expressed in BL-21 codon plus (Stratagene) as a GST fusion protein and purified using glutathione column chromatography, as described (Hoshino et al., submitted) . Vpr eluted after precision treatment was applied to an affinity column coupled with a monoclonal antibody to Vpr, 8D1. After washing, Vpr was eluted with 100 mM Hepes buffer (pH 2.5), and immediately neutralized with 1 M Hepes buffer (pH 8.0). The concentration of rVpr was measured by an enzyme-linked immunosorbent assay version-1 by using two antibodies against Vpr, a monoclonal antibody (8D1), and a polyclonal antibody raised against a peptide of the carboxy-terminus of Vpr (IBL).
